Microfluidic Chip Method Versus Density-gradient Centrifugation Method in IVF

ConditionInfertility
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 43
SponsorProfessor Ernest Hung-Yu Ng

About this trial

Infertile patients attending IVF treatment at the Centre of Assisted Reproduction and Embryology, Queen Mary Hospital and Kwong Wah Hospital will be recruited during ovarian stimulation for IVF. Subsequently, they will be randomly assigned on the day of oocyte retrieval by a laboratory staff into one of the following two groups: (1) the microfluidic chip group and (2) the density gradient group for sperm preparation and subsequent use in fertilization. Other IVF procedures will be the same as our usual practice. Both patients and clinicians were blinded from the group allocation i.e. a double blind study. The primary outcome is the cumulative live birth rate defined as the number of pregnancies leading to live birth within 6 months of randomisation.

Eligibility criteria

Qualifiers

Infertile women aged <43 years at the time of ovarian stimulation for IVF

Disqualifiers

Women undergoing preimplantation genetic testing monogenic diseases, structural rearrangement of chromosomes or aneuploidy;

Male factor requiring surgical sperm retrieval such as microscopic epididymal sperm aspiration and testicular sperm extraction;

Use of donor oocytes and spermatozoa;

Submucosal fibroid or hydrosalpinx shown on pelvic scanning and not surgically treated;

Trial design

Treatments tested in this trial

  • Microfluidic chip
  • Density-gradient centrifugation

Treatment groups

1,136 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Professor Ernest Hung-Yu Ng

Lead sponsor

The University of Hong Kong

Sponsor institution